Tricomin PC1358 topical peptide-copper compound: Began Phase II, placebo-controlled trial of two concentrations that will be applied twice a day in 36 men

ProCyte Corp. (PRCY), Kirkland, Wash. Product: Tricomin PC1358 topical peptide-copper compound Indication: Early stage pattern baldness (androgenic alopecia) Status: Began Phase II, placebo-controlled...